184 related articles for article (PubMed ID: 3330790)
1. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
[TBL] [Abstract][Full Text] [Related]
2. Activation of N-ras induced by ultraviolet irradiation in vitro.
Van der Lubbe JL; Rosdorff HJ; Bos JL; Van der Eb AJ
Oncogene Res; 1988; 3(1):9-20. PubMed ID: 3060800
[TBL] [Abstract][Full Text] [Related]
3. Amino-acid substitution at codon 13 of the N-ras oncogene in rectal cancer in a Japanese patient.
Nitta N; Ochiai M; Nagao M; Sugimura T
Jpn J Cancer Res; 1987 Jan; 78(1):21-6. PubMed ID: 3102434
[TBL] [Abstract][Full Text] [Related]
4. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
[TBL] [Abstract][Full Text] [Related]
5. Transformation of NIH3T3 cells by transfection with UV-irradiated human c-Ha-ras-1 proto-oncogene DNA.
Pierceall WE; Ananthaswamy HN
Oncogene; 1991 Nov; 6(11):2085-91. PubMed ID: 1945413
[TBL] [Abstract][Full Text] [Related]
6. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome.
Hirai H; Kobayashi Y; Mano H; Hagiwara K; Maru Y; Omine M; Mizoguchi H; Nishida J; Takaku F
Nature; 1987 Jun 4-10; 327(6121):430-2. PubMed ID: 3295562
[TBL] [Abstract][Full Text] [Related]
7. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
[TBL] [Abstract][Full Text] [Related]
8. Preferential and novel activation of H-ras in human bladder carcinomas.
Visvanathan KV; Pocock RD; Summerhayes IC
Oncogene Res; 1988; 3(1):77-86. PubMed ID: 3144694
[TBL] [Abstract][Full Text] [Related]
9. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
[TBL] [Abstract][Full Text] [Related]
10. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
[TBL] [Abstract][Full Text] [Related]
11. RAS mutations in patients following cytotoxic therapy for lymphoma.
Carter G; Hughes DC; Clark RE; McCormick F; Jacobs A; Whittaker JA; Padua RA
Oncogene; 1990 Mar; 5(3):411-6. PubMed ID: 2179819
[TBL] [Abstract][Full Text] [Related]
12. Colon carcinoma K-ras 2 oncogene of a familial polyposis coli patient.
Yuasa Y; Oto M; Sato C; Miyaki M; Iwama T; Tonomura A; Namba M
Jpn J Cancer Res; 1986 Sep; 77(9):901-7. PubMed ID: 3021699
[TBL] [Abstract][Full Text] [Related]
13. ras gene activation in a minor proportion of the blast population in acute myeloid leukemia.
Toksoz D; Farr CJ; Marshall CJ
Oncogene; 1987; 1(4):409-13. PubMed ID: 3330783
[TBL] [Abstract][Full Text] [Related]
14. Correlation between H-ras p21TLeu61 protein content and tumorigenicity of NIH3T3 cells.
Bizub D; Blair D; Alvord G; Skalka AM
Oncogene; 1988 Oct; 3(4):443-8. PubMed ID: 3078952
[TBL] [Abstract][Full Text] [Related]
15. Detection of activated ras oncogenes in human thyroid carcinomas.
Suárez HG; Du Villard JA; Caillou B; Schlumberger M; Tubiana M; Parmentier C; Monier R
Oncogene; 1988 Apr; 2(4):403-6. PubMed ID: 3283656
[TBL] [Abstract][Full Text] [Related]
16. ras mutations in human leukemia and related disorders.
Greenberger JS
Int J Cell Cloning; 1989 Nov; 7(6):343-59. PubMed ID: 2681441
[TBL] [Abstract][Full Text] [Related]
17. ras oncogene activation in human ovarian carcinoma.
van 't Veer LJ; Hermens R; van den Berg-Bakker LA; Cheng NC; Fleuren GJ; Bos JL; Cleton FJ; Schrier PI
Oncogene; 1988 Feb; 2(2):157-65. PubMed ID: 3285294
[TBL] [Abstract][Full Text] [Related]
18. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors.
Cardiff RD; Gumerlock PH; Soong MM; Dandekar S; Barry PA; Young LJ; Meyers FJ
Oncogene; 1988 Aug; 3(2):205-13. PubMed ID: 2842717
[TBL] [Abstract][Full Text] [Related]
19. Amino acid substitution at position 13 of the N-ras gene in a non-Hodgkin's lymphoma patient.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Haematol Blood Transfus; 1987; 31():172-4. PubMed ID: 3327770
[No Abstract] [Full Text] [Related]
20. Evaluation of potential oncogene alterations in the ENU1564 rat mammary tumor model.
Hal DG; Stoica G
Anticancer Res; 1994; 14(2A):481-7. PubMed ID: 7912494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
